Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Corporate Presentation

<< Previous

Bullboard Posts

Next >>

Comment by Rumpl3StiltSkinon Jun 29, 2023 7:26pm

218 Views

Post# 35521392

RE:RE:RE:RE:RE:Corporate Presentation

Yep, this jibes with what I've been thinking regarding AA. Pre-Approval is AA. I wonder if they are anticipating BTD to take a while, and AA also? Or is it they expect BTD approval in Q2/Q3? Or is that just when they will apply? Anyway, BTD should speed up the AA process by a ton. The current data looks good enough for it..

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments